Corcept Therapeutics reported $496.36M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US $ 612.77M 11.48M
Ani Pharmaceuticals ANIP:US $ 751.33M 6.49M
Aurora Cannabis Inc ACB:CN 1.57B 915.13M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Canopy Growth Corp WEED:CN C$ 3.52B 2.1B
Corcept Therapeutics CORT:US $ 496.36M 28.24M
Depomed DEPO:US $ 339.14M 12.59M
Eleven Biotherapeutics EBIO:US $ 225.84M 14.91M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Esperion Therapeutics ESPR:US $ 303.98M 38.87M
Knight Therapeutics Inc GUD:CN C$ 995.42M 3.53M
Lannett LCI:US $ 572.31M 22.63M
Lexicon Pharmaceuticals LXRX:US $ 112.32M 23.85M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Novartis NVS:US $ 122910M 2308M
Novartis NOVN:VX SF 122910M 2308M
Omeros OMER:US $ 369.26M 50M
Pacira Pharmaceuticals PCRX:US $ 1733.99M 157.49M
Supernus Pharmaceuticals SUPN:US $ 1694.97M 55.46M
Tg Therapeutics TGTX:US $ 251.67M 51.36M
Ziopharm Oncology ZIOP:US $ 84.99M 9.87M